Medical NewsHealth Bulletin 02/December/2025 DRRA4 weeks ago01 mins Health Bulletin 02/December/2025 We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link Post navigation Previous: Solid Biosciences’ SGT-212 gains FDA rare paediatric disease statusNext: Belite Bio Reports Topline P-III (DRAGON) Trial Data on Tinlarebant for Stargardt Disease Type 1 (STGD1) Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
Fenfluramine linked to significantly improved seizure outcomes vs. placebo at 14 weeks DRRA14 hours ago 0